Stay updated on GTX-102 Safety in Angelman Syndrome Kids Clinical Trial
Sign up to get notified when there's something new on the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page.

Latest updates to the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.3.3 was added to the page footer, and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedRevision history shows the addition of v3.3.2 and removal of v3.2.0, a minor internal update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedA notice about government funding and operating status was removed from the page. No other content appears to have changed.SummaryDifference0.4%

- Check64 days agoChange DetectedThe old and new screenshots show the same record history page with identical version entries; no substantive changes to study data or page functionality are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.SummaryDifference9%

- Check99 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.SummaryDifference0.2%

Stay in the know with updates to GTX-102 Safety in Angelman Syndrome Kids Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page.